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Abstract
This study compares the meat composition of the offspring from boars produced by somatic cell nuclear transfer (n = 4) to that of
the offspring from conventionally produced boars (n = 3). In total, 89 commercial gilts were artificially inseminated and 61
progressed to term and farrowed. All of the resulting piglets were housed and raised identically under standard commercial settings
and slaughtered upon reaching market weight. Loin samples were taken from each slaughtered animal and shipped offsite for meat
composition analysis. In total, loin samples from 404 animals (242 from offspring of clones and 162 from controls) were analyzed
for 58 different parameters generating 14,036 and 9396 data points from offspring of clones and the controls, respectively. Values
for controls were used to establish a range for each parameter. Ten percent was then added to the maximum and subtracted from the
minimum of the control range, and all results within this range were considered clinically irrelevant. Of the 14,036 data points from
the offspring of clones, only three points were found outside the clinically irrelevant range, two of which were within the range
established by the USDA National Nutrient Database for Standard Reference, Release 18, 2005; website: http://www.nal.usda.gov/
fnic/foodcomp/search/. The only outlier was the presence of Eicosadienoic acid (C20:2) in one sample which is typically present in
minute quantities in pork; no reference data were found regarding this fatty acid in the USDA National Nutrient Database. In
conclusion, these data indicated that meat from the offspring of clones was not chemically different than meat from controls and
therefore supported the case for the safety of meat from the offspring of clones.
# 2006 Elsevier Inc. All rights reserved.
Keywords: Pigs; Cloning; Meat composition; Cloned offspring; Food safety
1. Introduction
Cloning by nuclear transfer has the potential to
greatly enhance current agricultural practices but its
application has been limited by producer observation of
a voluntary moratorium until the United States Food
and Drug Administration (FDA) releases a final risk
assessment. The U.S. FDA released a draft executive
summary for the risk assessment of food products from
www.theriojournal.com
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cloned animals, which stated that meat and milk from
animals produced by cloning do not present a significant
risk increase over meat and milk products from animals
produced by conventional methods [2]. This report was
further supported by the National Academy of Sciences
which stated that clones are not likely to pose a food
consumption risk [3]. The FDA continues to gather
information regarding the safety of products derived
from cloned animals and their offspring.
Several reports have characterized the safety of
products from clones. Both meat and milk from animals
produced by nuclear transfer have been analyzed in a
number of studies and in all instances have been shown
to possess a similar composition to that from
conventionally produced animals [4–8]. Furthermore,
a feeding trial in rats demonstrated that the consumption
of meat from cloned animals had no effect on body
growth, food intake, general condition, locomotor
activity, reflexes, sexual cycle, urinalysis, hematology,
blood biochemistry, or histology [5,8].
Although these testswere conducted on products from
cloned animals, the likelihood of human consumption of
meat from clones is low. Cloningwill likely be utilized to
reproduce elite animals for greater dissemination of their
genetics and food products will be derived from their
conventionally produced offspring. As of yet, there has
been no study comparing the meat composition of the
offspring from individuals produced by nuclear transfer
to that of the offspring of conventionally produced
animals. This study was designed to address this matter.
Cloned and conventionally produced boars were bred to
commercial gilts and the resulting piglets were raised
under commercial conditions and slaughtered at a target
market weight. At slaughter, loin samples were obtained
and shipped to Eurofins Scientific Inc. (ESI, Memphis,
TN, USA) for compositional analysis of the meat. The
composition of the meat was then compared between the
offspring of clones and the controls utilizing previously
described methods [9].
2. Materials and methods
2.1. General swine husbandry
Eighty-nine gilts were artificially inseminated with
shipped boar semen resulting in the farrowing of 61 gilts,
as previously described [10]. Many phenotypic differ-
ences were observed within the litters (Fig. 1) due to the
genetic backgrounds of boars used in the study (terminal
cross lines).Within 12–24 h after birth, each live pig was
individually weighed, ear notched, needle teeth clipped,
injectfed with 100 mg iron dextran and 300,000 units of
procaine penicillin, tail docked and navel treated with
iodine. Within each litter, the following characteristics
were recorded: number born alive, number stillborn, and
number of mummified fetuses. No differences were
observed between the offspring of clones and controls
[10]. Within 36 h after birth, the pigs within clone or
control treatment were cross-fostered to adjust for litter
size (target of 8–10 pigs/litter).
Aveterinarian observed the pigs weekly for the first 4
weeks after birth and monthly thereafter for abnormal
health status and behavioral patterns. All treatments and
medications were recorded for individual pigs. Any pigs
that died post-weaning were necropsied to determine
cause of death. No differences in the health status or
mortality rates were observed between the offspring of
clones or controls (data not shown).
Starting at 56–59 days of age, barrows and gilts were
weighed on 28-day intervals (56–59, 84–87, 112–115,
and 140–143 days of age). A slaughter weight projection
was computed for a final weight of 123 kg, based on the
two most recent weights. All pigs were slaughtered
within7 days of their projected slaughter date. Animal
management, including vaccinations and rations, is
shown in Table 1.
2.2. Meat analysis
Following a 24-h chill at 0 8C, a sample (approxi-
mately 500 g) of Longissimus dorsi muscle anterior to
the tenth rib was collected, cryovac packed, frozen and
shipped overnight for nutrient analysis by Eurofins
Scientific Inc. (ESI; Table 2). Once at ESI, the samples
were logged in on the day of receipt and held at13 8C
until ready for homogenization. One day prior to
homogenization, the samples were removed from the
freezer and partially thawed overnight at 10–18 8C. The
samples were then homogenized using a commercial
grade meat grinder (NSF Model #MIN0012, (3/4) hp,
#12 blade, (1/8) in. screen). Following homogenization,
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Fig. 1. A litter of offspring derived from a cloned boar.
samples were divided and frozen. One set of samples
was sent to Des Moines for metals and cholesterol
analysis; all remaining analysis was conducted at the
Memphis location. Prior to testing, the samples were
removed and allowed to thaw overnight. All samples
were tested using recognized AOAC (Association of
Official Analytical Chemists) methods. The specific
AOAC methods utilized include amino acids profile
(AOAC 982.30), metals by ICP (AOAC 965.17 and
985.01), cholesterol (AOAC 994.10), fatty acids profile
(AOAC 996.06), niacin (AOAC 944.13), vitamin B12
(AOAC 952.20), and vitamin B6 (AOAC 961.15). All
data were recorded as g/100 g or as percent of total with
the following exceptions: niacin, vitamin B6 and
cholesterol were reported in mg/100 g units and vitamin
B12 was reported in mg/100 g units. At this point it was
visually obvious that there was some sample-to-sample
inhomogeneity, as some samples appeared to have more
fat than others. No efforts were made to correct this by
taking a sub-sample of the lean meat or measuring the
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Table 1
Management of cloned and control pigs
Day Procedure
1 (12–24 h) Piglets weighed, ear notched, needle teeth clipped, injected with iron dextran and 300,000 IU
procaine penicillin G, tails docked, navel treated with iodine
Within 36 h of birth Pigs within clone or control treatment were cross-fostered to adjust for litter size (target
of 8–10 pigs per litter)
3–6 Vaccinated intranasally with 1cc of PRRS (Boehringer Ingelheim, St. Joseph, MO, USA)
10 23% crude protein commercial creep feed offered
12–15 Vaccinated for Mycoplasma hyopneumonia (Respisure, Pfizer, New York, NY, USA)
Approximately 14 Male piglets castrated
Approximately 18 (range 14–20 days) Sows removed from farrowing stalls and piglets weaned. Pigs individually ear tagged and
vaccinated with Strep Shield 2 (Novartis, Basil, Switzerland) and PRRS intramuscularly
24 Starter ration offered (21% crude protein)
28 Pigs removed from farrowing stalls to nursery. Vaccinated for Mycoplasma hyopneumonia
32 Nursery ration offered (20% crude protein)
35 Vaccinated with Strep Shield 2
56–59 Vaccinated for Erysipelas (Grand Labs, Larchwood, IA, USA), PRRS, and treated with
Ivermectin (Durvet, Springfield, MO, USA)
66 (range 56–76 days) Sorted by sex, moved to a single finishing building in pens of 13–20 pigs per pen, and switched
to a grower ration (18% crude protein)
112–115 Switched to a finishing ration (16% crude protein)
Table 2
List of nutrients tested in cloned and control pigs
Alanine C10:0 Decanoic (Capric) C20:4 Eicosatetraenoic (Arachidonic)
Arginine C11:0 Undecanoic (Hendecanoic) C20:5 Eicosapentaenoic
Aspartic acid C12:0 Dodecanoic (Lauric) C21:5 Heneicosapentaenoic
Cystine C14:0 Tetradecanoic (Myristic) C22:0 Docosanoic (Behenic)
Glutamic acid C14:1 Tetradecenoic (Myristoleic) C22:1 Docosenoic (Erucic)
Glycine C15:0 Pentadecanoic C22:2 Docosadienoic
Histidine C15:1 Pentadecenoic C22:3 Docosatrienoic
Isoleucine C16:0 Hexadecanoic (Palmitic) C22:4 Docosatetraenoic
Leucine C16:1 Hexadecenoic (Palmitoleic) C22:5 Docosapentaenoic
Lysine C17:0 Heptadecanoic (Margaric) C22:6 Docosahexaenoic
Methionine C17:1 Heptadecenoic Margaroleic C24:0 Tetracosanoic (Lignoceric)
Phenylalanine C18:0 Octadecanoic (Stearic) C24:1 Tetracosenoic (Nervonic)
Proline C18:1 Octadecenoic (Oleic) Iron
Serine C18:2 Octadecadienoic (Linoleic) Niacin
Threonine C18:3 Octadecatrienoic (Linolenic) Phosphorus
Tyrosine C18:4 Octadecatetraenoic Vitamin B12
Valine C20:0 Eicosanoic (Arachidic) Vitamin B6
Calcium C20:1 Eicosenoic (Gadoleic) Zinc
Cholesterol C20:2 Eicosadienoic
C08:0 Octanoic (Caprylic) C20:3 Eicosatrienoic
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Table 3
Nutrient analysis results in cloned and control pigs
Control Offspring of clones No. of animals (offspring of
clones) within
Results
Minimum Maximum Average Minimum Maximum Average Range of
controls
10% of
controls
Greater
than 10%
Alanine 1.23 1.81 1.38 1.20 1.92 1.39 237 5 0
Arginine 1.34 2.31 1.58 1.31 2.30 1.58 241 1 0
Aspartic acid 1.62 3.02 2.29 1.63 3.33 2.30 241 0 1 3.33 (2.30)
Cystine 0.22 0.28 0.24 0.20 0.30 0.24 238 4 0
Glutamic acid 3.24 4.87 3.71 3.08 5.31 3.75 230 12 0
Glycine 0.86 1.69 1.11 0.87 1.84 1.13 240 2 0
Histidine 0.82 1.29 0.97 0.80 1.65 0.97 239 2 1 1.65 (1.09)
Isoleucine 0.76 1.33 1.03 0.73 1.58 1.03 238 3 1 1.58 (1.08)
Leucine 1.63 2.45 1.89 1.60 2.80 1.90 240 1 1 2.8 (1.91)
Lysine 1.73 2.76 2.07 1.67 3.19 2.06 239 2 1 3.19 (2.08)
Methionine 0.52 0.73 0.62 0.51 0.74 0.61 237 5 0
Phenylalanine 0.79 1.22 0.94 0.80 1.38 0.96 241 0 1 1.38 (0.79)
Proline 0.83 1.68 1.11 0.82 1.58 1.09 241 1 0
Serine 0.78 1.25 0.95 0.70 1.33 0.96 240 2 0
Threonine 0.92 1.45 1.08 0.75 1.61 1.09 239 1 2 1.61 (1.18) (0.75a)
Tyrosine 0.69 1.05 0.81 0.67 1.19 0.81 237 4 1 1.19(.81)
Valine 0.81 1.43 1.10 0.77 1.70 1.09 238 3 1 1.7 (1.16)
Calcium 0.0021 0.018 0.0054 0.0037 0.034 0.006 240 0 2 0.034 (0.0042),
0.021 (0.0045)
Cholesterol 45.6 85.1 59.4 45.4 91.1 57.9 240 2 0
C08:0 Octanoic (Caprylic) 0.01 0.01 0.01 0.00 0.00 0.00 242 0 0
C10:0 Decanoic (Capric) 0.01 0.02 0.01 0.01 0.02 0.01 242 0 0
C11:0 Undecanoic 0.00 0.00 0.00 0.00 0.00 0.00 242 0 0
C12:0 Dodecanoic (Lauric) 0.01 0.01 0.01 0.01 0.01 0.01 242 0 0
C14:0 Tetradecanoic 0.03 0.21 0.08 0.03 0.21 0.08 242 0 0
C14:1 Tetradecenoic 0.00 0.00 0.00 0.00 0.00 0.00 242 0 0
C15:0 Pentadecanoic 0.00 0.00 0.00 0.00 0.00 0.00 242 0 0
C15:1 Pentadecenoic 0.00 0.00 0.00 0.00 0.00 0.00 242 0 0
C16:0 Hexadecanoic 0.53 3.42 1.40 0.45 3.62 1.39 240 1 1 0.45 (0.99)
C16:1 Hexadecenoic 0.06 0.35 0.16 0.06 0.38 0.17 240 2 0
C17:0 Heptadecanoic 0.01 0.02 0.01 0.01 0.02 0.01 242 0 0
C17:1 Heptadecenoic 0.01 0.02 0.01 0.01 0.02 0.01 242 0 0
C18:0 Octadecanoic (Stearic) 0.21 1.75 0.68 0.21 1.77 0.66 241 1 0
C18:1 Octadecenoic (Oleic) 0.85 4.78 2.20 0.69 5.44 2.26 238 2 2 0.69 (1.76), 5.44
(5.67b)
C18:2 Octadecadienoic 0.08 0.80 0.29 0.06 0.92 0.30 239 0 3 0.07 (0.29), 0.06
(0.33), 0.92 (0.39)
C18:3 Octadecatrienoic 0.01 0.03 0.01 0.01 0.05 0.02 240 0 2 0.04 (0.01) 0.05 (.01)
C18:4 Octadecatetraenoic 0.01 0.02 0.01 0.01 0.01 0.01 242 0 0
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Table 3 (Continued )
Control Offspring of clones No. of animals (offspring of
clones) within
Results
Minimum Maximum Average Minimum Maximum Average Range of
controls
10% of
controls
Greater
than 10%
C20:0 Eicosanoic (Arachidic) 0.01 0.03 0.01 0.01 0.03 0.01 242 0 0
C20:1 Eicosenoic (Gadoleic) 0.01 0.26 0.07 0.02 0.22 0.08 242 0 0
C20:2 Eicosadienoic 0.01 0.03 0.02 0.01 0.04 0.02 240 0 2 0.04 (0.06b),
0.04 (0.03)
C20:3 Eicosatrienoic 0.00 0.00 0.00 0.01 0.01 0.01 241 0 1 0.01 (<0.01)
C20:4 Eicosatetraenoic 0.01 0.01 0.01 0.01 0.02 0.01 241 0 1 0.02 (<.01)
C20:5 Eicosapentaenoic 0.01 0.02 0.01 0.01 0.01 0.01 242 0 0
C21:5 Heneicosapentaenoic 0.00 0.00 0.00 0.01 0.01 0.01 242 0 0
C22:0 Docosanoic (Behenic) 0.00 0.00 0.00 0.00 0.00 0.00 242 0 0
C22:1 Docosenoic 0.01 0.04 0.02 0.01 0.04 0.01 242 0 0
C22:2 Docosadienoic 0.01 0.01 0.01 0.00 0.00 0.00 242 0 0
C22:3 Docosatrienoic 0.00 0.00 0.00 0.00 0.00 0.00 242 0 0
C22:4 Docosatetraenoic 0.00 0.00 0.00 0.00 0.00 0.00 242 0 0
C22:5 Docosapentaenoic 0.00 0.00 0.00 0.00 0.00 0.00 242 0 0
C22:6 Docosahexaenoic 0.01 0.08 0.02 0.01 0.06 0.02 242 0 0
C24:0 Tetracosanoic 0.00 0.00 0.00 0.00 0.00 0.00 242 0 0
C24:1 Tetracosenoic 0.00 0.00 0.00 0.00 0.00 0.00 242 0 0
Iron 0.0004 0.043 0.0009 0.0004 0.0057 0.001 242 0 0
Niacin 8.15 13.00 10.64 7.34 19.10 10.68 233 8 1 19.1 (8.78)
Phosphorus 0.02 0.22 0.16 0.02 0.72 0.18 236 5 1 0.72 (0.21)
Vitamin B12 0.35 1.88 0.97 0.42 2.20 1.01 241 0 1 2.2 (1.2)
Vitamin B6 0.22 0.59 0.38 0.23 0.60 0.40 241 1 0
Zinc 0.0011 0.0022 0.0015 0.0012 0.0046 0.002 239 1 2 0.0025 (0.0014),
0.0046 (0.0015)
The minimum, maximum and average values for 58 parameters are shown for the offspring of clones and controls. Additionally, the number of offspring of clones that were within the control range
and within or>10% of the control range is shown. The Results column shows initial values that were outside of the10% range and the retested values in parenthesis. All data are presented as g/
100 g or as percent of total with the following exceptions: niacin, vitamin B6 and cholesterol are presented as mg/100 g and vitamin B12 is presented as mg/100 g.
a This result was not retested.
b These results were outside of clinically irrelevant range after retesting.
total fat and normalizing for the fat content which likely
would have lead to greater consistency across groups.
2.3. Data analysis
The data were analyzed as described in a publication
by the FDAs Center for Veterinary Medicine [9]. Briefly
results from the control animals were utilized to establish
a range representing the minimum and maximum value
for each analyte. All results from the offspring of clones
fallingwithin this rangewere consideredwithin thenorm.
Ten percent was then added to the maximum and
subtracted from theminimumof the control range, and all
results within this range were considered outside the
comparison rangebut clinically irrelevant.Results falling
outside the10% range were potentially clinically rele-
vant and further evaluated by comparison to the USDA
National Nutrient Database for Standard Reference [1].
3. Results
In this study, 404 loin samples, 242 samples from the
offspring of clones and 162 from the controls, were
analyzed for 58 different parameters (Table 2) generating
23,432 data points. A total of 14,036 results were
obtained for the offspring of the clones; 13,936 were
determined to be within the range established for the
controls (falling between minimum and maximum of
control). Seventy-one results fell outside the control
range but were within10% of it and were therefore not
considered to be clinically relevant. The remaining 29
results fell outside 10% of the control range (Table 3).
Twenty-eight samples corresponding to these results
were submitted for retesting. One sample from pig
200437509 was not retested due to an oversight. Only
two of the new results fell outside the clinically
irrelevant range (Table 3).
4. Discussions
The classic approach to the compositional analysis of
food is a targeted one; rather than analyzing every single
constituent, which would be impractical, the aim is to
analyzeonly those constituentsmost relevant to the safety
of the food or that may have an impact on the overall diet.
The base set of constituents commonly analyzed includes
the key nutrients that may vary from food to food.
Analysis of elements other than the key constituents is
generally not considered necessary [11]. The question of
the appropriate comparator formeatsmay be approached
from two perspectives. In order to determine whether
cloning results in potential food consumption hazards,
one approach is to compare animals that are matched as
closely as possible by age, genetics, husbandry and
environment. The second approach is to compare meat
samples from clones and their offspring to the national
herds by using composite data sources [9].
Of the 14,036 data points from the offspring of
clones, 29 points were initially found to be outside the
control range. Twenty-eight samples corresponding to
these points were retested and 26 of the new results fell
within the clinically irrelevant range. One sample was
not retested due to an oversight; pig 200437509 had a
Threonine result of 0.75% which was outside the
clinically irrelevant range of the controls (0.828–
1.595%) for this study, but within the Threonine range
for pork as reported in the USDA National Nutrient
Database [1], in which pork samples ranged from 0.265
to 4.581% (NDBNos. 10218 and 10048). The change in
results from the 26 samples could be due to multiple
factors, including the low concentration of the nutrient
tested, the lack in sensitivity of the test at these lower
levels, and/or inhomogeneity of the samples tested.
From visual observation it was clear that some samples
contained more fat than others. As no attempt was made
to trim the fat to increase homogeneity, it is likely that
sample-to-sample variation was high, which likely
caused a high level of variation in the results.
Of the two retested samples that were outside the
clinically irrelevant range, onewas from pig 200438107,
which had an original C18:1 Octadecenoic (Oleic) result
of 5.44%and a retest value of 5.66% (Fig. 2). Both values
were outside the clinically irrelevant range for the
controls of 0.765–5.258% but within the range for pork
loin as reported in the USDANational Nutrient Database
[1]; C18:1 in pork can range from 0.130 to 23.315% of
total (NDBNos. 10020 and 10225). As stated above, this
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Fig. 2. Distribution of Octadecenoic acid in loin samples of offspring
of cloned and control pigs. Offspring of , clones; , controls; __ __ __,
denotes range of controls;   , denotes range of controls 10%; each
point represents the result from an individual animal (404 total).
USDA National Nutrient Database for Standard Reference, Octade-
cenoic acid range from 0.130 to 23.315% (NDB Nos. 10020 and
10225).
value appears to be highly correlated to the level of fat in
the sample as the USDA National Nutrient Database for
Standard Reference samples containing fat showed a
much higher level of C18:1 than the samples lacking fat.
The other retested sample was from pig 200430710
which had an original C20:2 Eicosadienoic result of
0.04% and a retest of 0.06%, whichwere both outside the
clinically irrelevant range of the controls 0.009–0.033%.
Meat by definition contains several tissue types and each
varies according to the genetics, nutrition, and environ-
ment of the food animal. There are no full chemical
characterizations for meats [9]. No data were found
regarding expected C20:2 levels in pork, likely due to its
low concentration within the samples.
These data demonstrated that meat from the
offspring of cloned swine was not chemically different
than meat from conventionally produced animals.
Combined with previous research regarding the safety
of meat and milk products derived directly from cloned
animals [4–8], these results expanded the body of
scientific knowledge on which governmental agencies
across the world are basing their decisions regarding the
approval of human consumption of food products
derived from clones and their offspring.
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